glp 1 arthritis pain GLP-1 Medications and Rheumatoid Arthritis: What a New Study Shows Targeting the GLP-1/GLP-1R axis to

Prader-Willi syndrome: A model for understanding the ghrelin system

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

It protects joints, keeps balance steady, and fuels the metabolism that helps you maintain your weight

Disclosures: Ai-Thien Do: Nothing to Disclose, Ming-Lung Yu: Abbvie, Gilead and Roche diagnostics.: Grant/Research Support, Abbott, Abbvie, Gilead, Roche and Roche diagnostics: Consultant, Abbvie, BMS, Gilead, Roche and Roche diagnostics: Speaking and Teaching, Hidenori Toyoda: Nothing to Disclose, Seng Gee Lim: Nothing to Disclose, Ramsey Cheung: Nothing to Disclose, Man-Fung Yuen: Nothing to Disclose, Yasuhito Tanaka: Nothing to Disclose, Wan Long Chuang: Gilead: Speaking and Teaching, AbbVie: Speaking and Teaching, BMS: Speaking and Teaching, Vaccitech: Consultant, PharmaEssentia: Consultant, Chao Wu: Nothing to Disclose, Maria Buti: Nothing to Disclose, Nothing to Disclose, Adrian Gadano: Nothing to Disclose, Ming-Lun Yeh: Nothing to Disclose, Chung-Feng Huang: Nothing to Disclose, Rui Huang: Nothing to Disclose, Jee-Fu Huang: Nothing to Disclose, Chia-Yen Dai: Nothing to Disclose, Mayumi Maeda: Nothing to Disclose, Kaori Inoue: Nothing to Disclose, Chul-Jin Lee: Nothing to Disclose, Cheng-Hao Tseng: Nothing to Disclose, Ana Barreira: Nothing to Disclose, Rex Wan-Hin Hui: Nothing to Disclose, Kwan-Lung Ko: Nothing to Disclose, Yoko Yoshimaru: Nothing to Disclose, Takanori Suzuki: Nothing to Disclose, Irina Sandra: Nothing to Disclose, Raluca Marin: Nothing to Disclose, Vy Nguyen: Nothing to Disclose, Yao-Chun Hsu: Gilead Sciences: Grant/Research Support, Gilead Sciences: Advisor, Sysmex: Advisor, Abbvie: Speaking and Teaching, Bristol Myers Squibb: Speaking and Teaching, Gilead Sciences: Speaking and Teaching, Roch: Speaking and Teaching, Huy Trinh: Nothing to Disclose, Jiayi Li: Nothing to Disclose, jianqing zhang: Nothing to Disclose, Eiichi Ogawa: Gilead Sciences: Grant/Research Support, Dong Hyun Lee: Nothing to Disclose, Takanori Ito: Chugai Pharmaceutical Co., Ltd.: Grant/Research Support, Chugai Pharmaceutical Co., Ltd

Disse aktiviteter gr det lettere at forst komplekse ledelsessituationer og styrker dine problemlsningsevner